ANGPT2 and Hutchinson-Gilford progeria syndrome: Therefore, exploring combination therapies would be a promising approach, including testing whether Ang2 treatment synergizes with other potential therapies for HGPS, such as farnesyl transferase inhibitors (FTIs), senolytics, gene therapy, rapamycin, and telomere therapy.